These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 25560847)

  • 21. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
    Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
    J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic Stress Gastropathy Prophylaxis May Not Be Necessary in At-Risk Surgical Trauma ICU Patients Tolerating Enteral Nutrition.
    Palm NM; McKinzie B; Ferguson PL; Chapman E; Dorlon M; Eriksson EA; Jewett B; Leon SM; Privette AR; Fakhry SM
    J Intensive Care Med; 2018 Jul; 33(7):424-429. PubMed ID: 27837045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit.
    Song MJ; Kim S; Boo D; Park C; Yoo S; Yoon HI; Cho YJ
    Sci Rep; 2021 Sep; 11(1):18467. PubMed ID: 34531488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress Ulcer Prophylaxis.
    Barletta JF; Bruno JJ; Buckley MS; Cook DJ
    Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stress ulcer prophylaxis in critically ill children: Protocol for a systematic review.
    Jensen MM; Marker S; Do HQ; Perner A; Møller MH
    Acta Anaesthesiol Scand; 2019 Aug; 63(7):966-972. PubMed ID: 30907441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enteral nutrition better than proton pump inhibitors?
    Jalil BA; El-Kersh K
    Curr Opin Crit Care; 2019 Aug; 25(4):334-339. PubMed ID: 31082823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.
    Steinberg KP
    Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
    Barletta JF; Sclar DA
    Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis.
    Yao DWJ; Ong C; Eales NM; Sultana R; Wong JJ; Lee JH
    J Pediatr; 2021 Jan; 228():164-176.e7. PubMed ID: 32916144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress-related mucosal disease: risk factors and prophylactic therapy.
    Spirt MJ
    Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
    Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress ulcer prophylaxis in the postoperative period.
    Allen ME; Kopp BJ; Erstad BL
    Am J Health Syst Pharm; 2004 Mar; 61(6):588-96. PubMed ID: 15061430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of gastrointestinal bleeding due to stress ulceration: a review of current literature.
    Pilkington KB; Wagstaff MJ; Greenwood JE
    Anaesth Intensive Care; 2012 Mar; 40(2):253-9. PubMed ID: 22417019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stress ulcer prophylaxis: still a valid option in the 1990s?
    Schepp W
    Digestion; 1993; 54(4):189-99. PubMed ID: 7902305
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing the gastrointestinal consequences of stress-related mucosal disease.
    Metz DC
    Curr Med Res Opin; 2005 Jan; 21(1):11-8. PubMed ID: 15881471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress ulcer prophylaxis in critical illness: a Canadian survey.
    Shears M; Alhazzani W; Marshall JC; Muscedere J; Hall R; English SW; Dodek PM; Lauzier F; Kanji S; Duffett M; Barletta J; Alshahrani M; Arabi Y; Deane A; Cook DJ
    Can J Anaesth; 2016 Jun; 63(6):718-24. PubMed ID: 26911559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.